(Discontinuation of Disclosed Matters)
Notice of Preparation for IPO of U.S. Subsidiary REALM IDx, Inc.

To whom it may concern,

Company Name: Konica Minolta, Inc.
Representative: Toshimitsu Taiko, President and CEO
Stock Exchange Listing: Tokyo Prime Market
Local Securities Code Number: 4902
Contact: Miwa Okamura, Corporate Senior Vice President, General Manager, Corporate Communications Division
Tel: (81) 3-6250-2111

The Company announces that its Representative Executive Officer has decided, on March 6, 2024, to transfer the entire equity capital of Invicro, LLC (headquartered in Massachusetts, U.S.A., hereinafter “Invicro”) to Calyx Services Inc. (headquartered in Delaware, U.S.A.). Details of the transfer are in the Company’s timely disclosure “Notice Regarding Change in a Consolidated Subsidiary (Transfer of Equity Capital)” dated today. Invicro supports drug discovery and is held by the Company through REALM IDx, Inc. (headquartered in California, USA, hereinafter “REALM IDx”) that operates the precision medicine business.

In conjunction with this, the Company has also decided to discontinue the preparations for REALM IDx's possible listing on the U.S. stock market.

The Company will also actively consider utilization of third-party equity for the remaining precision medicine business in order to work on the strategic challenges outlined in the Medium-term Business Plan.

Reference: Background to date

The Company announced, on November 2, 2021, that REALM IDx was preparing for possible listing on the U.S. stock market. REALM IDx continued such preparations since that time, while closely monitoring developments in the U.S. stock market. In light of the market conditions thereafter, REALM IDx was weighing when the time was right (announced on November 2, 2022).

As the precision medicine business needs continued investment for further growth acceleration, the Company decided to proceed to analyze its strategic options, including the possible sale of the business to a third party, to accelerate the growth of the business, and the possible listing on the U.S. stock market that had been in preparation, among others (disclosed on May 10, 2023).